Amersfoort, Netherlands

Horace R Davis

This inventor holds 2 USPTO granted patents. Top assignee: Cordis Corporation. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 530(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Horace R Davis: Innovator in Vascular Technology

Introduction

Horace R Davis is a notable inventor based in Amersfoort, Netherlands. He has made significant contributions to the field of vascular technology, particularly with his innovative designs that enhance medical procedures.

Latest Patents

Davis holds 2 patents for his groundbreaking work. His latest patents include a vascular filter convertible to a stent and method. This vascular filter is designed for temporary or permanent implantation within a body vessel to filter particulates or thrombus in the bloodstream. It is capable of being converted some time after initial implantation into a tubular stent. In this configuration, the stent tends to hold the vessel open without any significant filtering effect. The convertible filter/stent may have a tubular metal mesh structure and can form one or more filter lattices when in the filter configuration.

Career Highlights

Davis is currently associated with Cordis Corporation, where he continues to develop innovative medical devices. His work has been instrumental in advancing vascular treatment options.

Collaborations

Some of his notable coworkers include Gjalt Bosma and Hendrik G Breedveld. Their collaboration has contributed to the success of various projects within the company.

Conclusion

Horace R Davis is a prominent figure in the field of vascular technology, with a focus on innovative solutions that improve patient outcomes. His contributions through patents and collaboration with other professionals highlight his commitment to advancing medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…